You are currently viewing a new version of our website. To view the old version click .

Human Immunodeficiency Virus (HIV)

This special issue belongs to the section “Molecular Microbiology“.

Special Issue Information

Dear Colleagues,

Human immunodeficiency virus (HIV) remains a major public health concern due to the increasing number of infections (1.7 million new infections in 2019, with 38 million infected globally). HIV’s ability to persist in latent reservoirs is one of the major barriers to its eradication. Thus, we urgently need to develop new strategies to understand the mechanisms underlying the latency of HIV and new compounds to minimize the damage to cells of infected patients. In addition, new vaccine strategies are needed to decrease the global number of infections. Consequently, molecular and clinical research is important to improving our knowledge of viral and cellular factors that impact the pathogenicity and latency of HIV. Moreover, the analysis of interdependent consequences of viral factors and host responses has the potential to reveal important pathways involved in the pathogenicity of HIV. In this Special Issue, we invite contributors to publish their research on HIV’s molecular biology, the molecular basis of HIV’s pathogenicity, latent infection, innate immune evasion strategies, and the development of new vaccines.

Dr. Mª Ángeles Muñoz Fernández
Dr. Ignacio Rodríguez Relaño
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • HIV
  • immunopathology
  • virus–cell interaction
  • viral latency
  • immune signaling pathways
  • vaccines

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Int. J. Mol. Sci. - ISSN 1422-0067